A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT04437862
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 121 participants
- Sponsor
- MIVI Neuroscience, Inc.
- Registry
-
NCT04437862
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, France
- Registry status
- Completed
Technical summary
Registry record NCT04437862. Allocation not applicable; no masking; primary purpose treatment. Start 2020-10-27 (actual); primary completion 2023-04-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
- Acronym
- EvaQ
- Condition
- Acute Stroke
- Condition
- Cerebral Ischemia
- Intervention (Device)
- Q Revascularization System
- Lead sponsor
- MIVI Neuroscience, Inc.
Record details
- Record id
cardio:ct-nct04437862- Content hash
9fcbdd17a920d08cbfba871f0e0249b75b1af550fab14d864a66ea6bf2cf127a